Lu Cao

525 total citations
24 papers, 402 citations indexed

About

Lu Cao is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lu Cao has authored 24 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Lu Cao's work include Cancer Immunotherapy and Biomarkers (3 papers), Viral Infections and Immunology Research (3 papers) and Immune cells in cancer (3 papers). Lu Cao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Viral Infections and Immunology Research (3 papers) and Immune cells in cancer (3 papers). Lu Cao collaborates with scholars based in China, Australia and United States. Lu Cao's co-authors include Shaobo Xiao, Liurong Fang, Rui Luo, Huanchun Chen, Dang Wang, Yao Zhong, Zheng Xu, Weien Zhou, Xianqi Chen and Wen Yao and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Transplantation.

In The Last Decade

Lu Cao

21 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Cao China 8 118 108 61 61 57 24 402
Liyi Chen China 14 129 1.1× 54 0.5× 24 0.4× 71 1.2× 38 0.7× 67 529
Xiaotian Song China 12 125 1.1× 28 0.3× 14 0.2× 116 1.9× 35 0.6× 22 416
Weili Wang China 13 181 1.5× 50 0.5× 19 0.3× 61 1.0× 59 1.0× 32 474
Bhavesh Borate United States 13 283 2.4× 55 0.5× 8 0.1× 112 1.8× 154 2.7× 22 713
Gökhan Karakülah Türkiye 14 471 4.0× 148 1.4× 21 0.3× 42 0.7× 101 1.8× 63 711
Xiaolu Lu Australia 10 66 0.6× 17 0.2× 52 0.9× 90 1.5× 167 2.9× 29 450
Smarti Reel United Kingdom 4 299 2.5× 71 0.7× 11 0.2× 25 0.4× 7 0.1× 5 537
Xiaoning Wang China 17 290 2.5× 82 0.8× 25 0.4× 263 4.3× 150 2.6× 41 820
Zhaoshan Liu China 9 176 1.5× 36 0.3× 14 0.2× 65 1.1× 15 0.3× 19 390
Ke Yuan China 13 254 2.2× 162 1.5× 3 0.0× 32 0.5× 31 0.5× 52 615

Countries citing papers authored by Lu Cao

Since Specialization
Citations

This map shows the geographic impact of Lu Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Cao more than expected).

Fields of papers citing papers by Lu Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Cao. The network helps show where Lu Cao may publish in the future.

Co-authorship network of co-authors of Lu Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Cao. A scholar is included among the top collaborators of Lu Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Cao. Lu Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Angela Yee‐Moon, et al.. (2025). The association between fractalkine/CX3CR1 axis with IgA vasculitis and nephritis. Pediatric Research. 99(2). 740–747.
2.
Cao, Lu, Wei Li, Min Yang, et al.. (2025). Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 13(2). e010947–e010947. 2 indexed citations
3.
Cao, Lu, Rui Gu, Qin Wang, et al.. (2025). Risk factors and retreatment for relapse in childhood primary nephrotic syndrome treated with rituximab. Pediatric Nephrology. 40(5). 1635–1644.
4.
Li, Jiong, Zhe Yang, Zhenhu He, et al.. (2024). ZMAT2 condensates regulate the alternative splicing of TRIM28 to reduce cellular ROS accumulation, thereby promoting the proliferation of HCC cells. Cell Communication and Signaling. 22(1). 407–407. 2 indexed citations
6.
Cao, Lu, Xiaoqian Ma, Juan Zhang, et al.. (2023). PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma. Discover Oncology. 14(1). 134–134. 2 indexed citations
8.
Zhang, Juan, Xiaoqian Ma, Lu Cao, et al.. (2022). Enhancing and stabilization of cord blood regulatory T-cell suppressive function by human mesenchymal stem cell (MSC)-derived exosomes. Clinical & Experimental Immunology. 208(3). 255–267. 7 indexed citations
9.
Zhang, Juan, Lu Cao, Pengfei Rong, et al.. (2021). Benefit of Belatacept in Cord Blood-Derived Regulatory T Cell-Mediated Suppression of Alloimmune Response. Cell Transplantation. 30. 4211104412–4211104412. 2 indexed citations
10.
Liu, Juan, et al.. (2019). A Low-cost Mobile VR Walkthrough System for Displaying Multimedia Works Based on Unity3D. 27. 415–419. 1 indexed citations
11.
Zhang, Zhigang, Lu Cao, Xin Wang, et al.. (2019). Simultaneous In Situ Visualization and Quantitation of Dual Antigens Adsorbed on Adjuvants Using High Content Analysis. Nanomedicine. 14(19). 2535–2548. 5 indexed citations
12.
Cao, Lu, et al.. (2019). (3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ. Immunopharmacology and Immunotoxicology. 41(6). 599–606. 1 indexed citations
13.
Liu, Jun, Limin Peng, Zhichao Feng, et al.. (2018). Changes in default mode network connectivity in different glucose metabolism status and diabetes duration. NeuroImage Clinical. 21. 101629–101629. 32 indexed citations
15.
Cao, Lu, Xin Wang, Mujin Fang, Ningshao Xia, & Qinjian Zhao. (2016). Detection of subtle differences in analogous viral capsid proteins by allowing unrestricted specific interaction in solution competition ELISA. Journal of Virological Methods. 236. 1–4. 7 indexed citations
16.
Wang, Dang, Lu Cao, Zheng Xu, et al.. (2013). MiR-125b Reduces Porcine Reproductive and Respiratory Syndrome Virus Replication by Negatively Regulating the NF-κB Pathway. PLoS ONE. 8(2). e55838–e55838. 85 indexed citations
17.
Sui, Chengjun, Lu Cao, Bin Li, et al.. (2012). Anatomical versus nonanatomical resection of colorectal liver metastases: a meta-analysis. International Journal of Colorectal Disease. 27(7). 939–946. 25 indexed citations
18.
Wang, Dang, Liurong Fang, Jing Bi, et al.. (2011). Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced RANTES transcription in PK-15 cells. Virus Genes. 42(3). 388–393. 16 indexed citations
19.
Xu, Zheng, Shaobo Xiao, Peng Xu, et al.. (2011). miR-365, a Novel Negative Regulator of Interleukin-6 Gene Expression, Is Cooperatively Regulated by Sp1 and NF-κB. Journal of Biological Chemistry. 286(24). 21401–21412. 109 indexed citations
20.
Cao, Lu, et al.. (2001). [Association analysis of attempted suicide and 5-HT2A receptor gene].. PubMed. 18(3). 195–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026